BACKGROUND: Skeletal muscle (SM) mass decreases with advanced age and with disease in HIV infection. It is unknown whether age-related muscle loss is accelerated in the current era of antiretroviral therapy and which factors might contribute to muscle loss among HIV-infected adults. We hypothesized that muscle mass would be lower and decline faster in HIV-infected adults than in similar-aged controls. METHODS: Whole-body (1)H-magnetic resonance imaging was used to quantify regional and total SM in 399 HIV-infected and 204 control men and women at baseline and 5 years later. Multivariable regression identified associated factors. RESULTS: At baseline and Year 5, total SM was lower in HIV-infected than control men. HIV-infected women were similar to control women at both time points. After adjusting for demographics, lifestyle factors, and total adipose tissue, HIV infection was associated with lower Year 5 SM in men and higher SM in women compared with controls. Average overall 5-year change in total SM was small and age related, but rate of change was similar in HIV-infected and control men and women. CD4 count and efavirenz use in HIV-infected participants were associated with increasing SM, whereas age and stavudine use were associated with decreasing SM. CONCLUSIONS: Muscle mass was lower in HIV-infected men compared with controls, whereas HIV-infected women had slightly higher SM than control women after multivariable adjustment. We found evidence against substantially faster SM decline in HIV infected versus similar-aged controls. SM gain was associated with increasing CD4 count, whereas stavudine use may contribute to SM loss.
BACKGROUND: Skeletal muscle (SM) mass decreases with advanced age and with disease in HIV infection. It is unknown whether age-related muscle loss is accelerated in the current era of antiretroviral therapy and which factors might contribute to muscle loss among HIV-infected adults. We hypothesized that muscle mass would be lower and decline faster in HIV-infected adults than in similar-aged controls. METHODS: Whole-body (1)H-magnetic resonance imaging was used to quantify regional and total SM in 399 HIV-infected and 204 control men and women at baseline and 5 years later. Multivariable regression identified associated factors. RESULTS: At baseline and Year 5, total SM was lower in HIV-infected than control men. HIV-infectedwomen were similar to control women at both time points. After adjusting for demographics, lifestyle factors, and total adipose tissue, HIV infection was associated with lower Year 5 SM in men and higher SM in women compared with controls. Average overall 5-year change in total SM was small and age related, but rate of change was similar in HIV-infected and control men and women. CD4 count and efavirenz use in HIV-infectedparticipants were associated with increasing SM, whereas age and stavudine use were associated with decreasing SM. CONCLUSIONS: Muscle mass was lower in HIV-infectedmen compared with controls, whereas HIV-infectedwomen had slightly higher SM than control women after multivariable adjustment. We found evidence against substantially faster SM decline in HIV infected versus similar-aged controls. SM gain was associated with increasing CD4 count, whereas stavudine use may contribute to SM loss.
Authors: Rebecca Scherzer; Wei Shen; Steven B Heymsfield; Cora E Lewis; Donald P Kotler; Mark Punyanitya; Peter Bacchetti; Michael G Shlipak; Carl Grunfeld Journal: Obesity (Silver Spring) Date: 2010-06-10 Impact factor: 5.002
Authors: S Grinspoon; C Corcoran; K Miller; B M Biller; H Askari; E Wang; J Hubbard; E J Anderson; N Basgoz; H M Heller; A Klibanski Journal: J Clin Endocrinol Metab Date: 1997-05 Impact factor: 5.958
Authors: Andy Choi; Rebecca Scherzer; Peter Bacchetti; Phyllis C Tien; Michael S Saag; Cynthia L Gibert; Lynda A Szczech; Carl Grunfeld; Michael G Shlipak Journal: Am J Kidney Dis Date: 2010-08-14 Impact factor: 8.860
Authors: G Tsekes; G Chrysos; G Douskas; D Paraskeva; N Mangafas; D Giannakopoulos; M Papanikolaou; E Georgiou; M C Lazanas Journal: HIV Med Date: 2002-04 Impact factor: 3.180
Authors: Bret H Goodpaster; Seok Won Park; Tamara B Harris; Steven B Kritchevsky; Michael Nevitt; Ann V Schwartz; Eleanor M Simonsick; Frances A Tylavsky; Marjolein Visser; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2006-10 Impact factor: 6.053
Authors: Kristine M Erlandson; Douglas Kitch; Camlin Tierney; Paul E Sax; Eric S Daar; Pablo Tebas; Kathleen Melbourne; Belinda Ha; Nasreen C Jahed; Grace A McComsey Journal: AIDS Date: 2013-08-24 Impact factor: 4.177
Authors: Rebecca Scherzer; Steven B Heymsfield; Daniel Lee; William G Powderly; Phyllis C Tien; Peter Bacchetti; Michael G Shlipak; Carl Grunfeld Journal: AIDS Date: 2011-07-17 Impact factor: 4.177
Authors: Paula Debroy; Jordan E Lake; Myung Sim; Kristine M Erlandson; Julian Falutz; Carla M Prado; Todd T Brown; Giovanni Guaraldi; The Modena Hiv Metabolic Cohort Team Journal: Antivir Ther Date: 2019
Authors: Monty Montano; Shalender Bhasin; Richard T D'Aquila; Kristine M Erlandson; William J Evans; Nicholas T Funderburg; Amy Justice; Lishomwa C Ndhlovu; Bisola Ojikutu; Marco Pahor; Savita Pahwa; Alice S Ryan; Jennifer Schrack; Michael B Schultz; Paola Sebastiani; David A Sinclair; Julia Tripp; Bruce Walker; Julie A Womack; Raymond Yung; R Keith Reeves Journal: AIDS Res Hum Retroviruses Date: 2019-09-23 Impact factor: 2.205
Authors: Philip M Grant; Douglas Kitch; Grace A McComsey; Ann C Collier; Benedetta Bartali; Susan L Koletar; Kristine M Erlandson; Jordan E Lake; Michael T Yin; Kathy Melbourne; Belinda Ha; Todd T Brown Journal: AIDS Date: 2016-11-28 Impact factor: 4.177
Authors: Krisann K Oursler; Janet P Tate; Thomas M Gill; Kristina Crothers; Todd T Brown; Stephen Crystal; Julie Womack; David A Leaf; John D Sorkin; Amy C Justice Journal: AIDS Res Hum Retroviruses Date: 2013-06-26 Impact factor: 2.205
Authors: Todd T Brown; Yun Chen; Judith S Currier; Heather J Ribaudo; Jennifer Rothenberg; Michael P Dubé; Robert Murphy; James H Stein; Grace A McComsey Journal: J Acquir Immune Defic Syndr Date: 2013-07-01 Impact factor: 3.731
Authors: Kristine M Erlandson; Amanda A Allshouse; Catherine M Jankowski; Samantha MaWhinney; Wendy M Kohrt; Thomas B Campbell Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731